Effect of phospholipase C blockade on cerebral vasospasm

Cerebrovascular Diseases

Volumn 25, Issue 4, 2008, Pages 362-365

  Jadhav, Vikram D ^a   Jabre, Anthony ^b,d   Lee, Tony Jer Fu ^a,c  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c TZU CHI UNIVERSITY   (Taiwan)

^d St Francis Healthcare Centers   (United States)

Author keywords

Neomycin; Oxyhemoglobin; Phospholipase C; Thromboxane A2; Vasospasm

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; NEOMYCIN; OXYHEMOGLOBIN; PHOSPHOLIPASE C; THROMBOXANE A2;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BASILAR ARTERY; BRAIN VASOSPASM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; BASILAR ARTERY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME INHIBITORS; NEOMYCIN; OXYHEMOGLOBINS; SUBARACHNOID HEMORRHAGE; SWINE; THROMBOXANE A2; TYPE C PHOSPHOLIPASES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 42349092444     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000118383     Document Type: Article

References (39)

1. Ingall T, Asplund K, Mahonen M, et al: A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke 2000;31:1054-1061.
2. Broderick JP, Brott TG, Duldner JE, et al: Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 1994;25:1342-1347.
3. Kassell NF, Haley EC Jr, Apperson-Hansen C, et al: Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg 1996;84:221-228.
4. Seiler RW, Binggeli R: Is cerebral vasospasm still a clinical problem? Acta Neurochir Suppl 2001;77:1-4.
5. Weir B, Macdonald RL, Stoodley M: Etiology of cerebral vasospasm. Acta Neurochir Suppl (Wien) 1999;72:27-46.
6. Dehdashti AR, Mermillod B, Rufenacht DA, Reverdin A, de Tribolet N: Does treatment modality of intracranial ruptured aneurysms influence the incidence of cerebral vasospasm and clinical outcome? Cerebrovasc Dis 2004;17:53-60.
7. Hempelmann RG, Pradel RH, Barth HL, et al: Interactions between vasoconstrictors in isolated human cerebral arteries. Acta Neurochir (Wien) 1997;139:574-581.
8. Jones RL, Shum WW, Gurney AM: Synergism between prostanoids and other vasoactive agents. J Card Surg 2002;17:436-438.
9. Jabre A, Jadhav V, Lee T: Oxyhemoglobin potentiation of thromboxane A2-induced contraction of porcine basilar arteries; in Macdonald RL (ed): Cerebral Vasospasm. Advances in Research and Treatment. New York, Thieme, 2004, pp 116-118.
10. Jadhav V, Jabre A, Lin SZ, et al: EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries. J Cereb Blood Flow Metab 2004;24:1305-1316.
11. Linnik MD, Lee TJF: Effect of hemoglobin on neurogenic responses and cholinergic parameters in porcine cerebral arteries. J Cereb Blood Flow Metab 1989;9:219-225.
12. Vollrath BA, Weir BK, Macdonald RL, et al: Intracellular mechanisms involved in the responses of cerebrovascular smooth muscle cells to hemoglobin. J Neurosurg 1994;80:261-268.
13. Zhang W, Edvinsson L, Lee TJF: Mechanism of nicotine-induced neurogenic vasodilation in the porcine basilar artery. J Pharmacol Exp Ther 1998;284:790-797.
14. Cook DA: Mechanisms of cerebral vasospasm in subarachnoid hemorrhage. Pharmacol Ther 1995;66:259-284.
15. Tsuji T, Cook DA: Changes in vascular responses of isolated and perfused canine basilar arteries during early stages of experimental subarachnoid hemorrhage. Proc West Pharmacol Soc 1987;30:285-289.
16. Ciuffi M, Tarlini L, Mugnai S, et al: Hemoglobin affects lipid peroxidation and prostaglandin E2 formation in rat corticocerebral tissues in vitro. Biochem Pharmacol 1996;52:97-103.
17. Guilivi C, Hochstein P, Davies KJA: Hydrogen peroxide production by red blood cells. Free Radic Biol Med 1994;16:123-129.
18. Mayberg MR, Okada T, Bark DH: The role of hemoglobin in arterial narrowing after subarachnoid hemorrhage. J Neurosurg 1990;72:634-640.
19. Sano K, Asano T, Tanishima T, et al: Lipid peroxidation as a cause of cerebral vasospasm. Neurol Res 1980;2:253-272.
20. Sasaki T, Wakai S, Asano T, et al: The effect of lipid hydroperoxide of arachidonic acid on the canine basilar artery: an experimental study on cerebral vasospasm. J Neurosurg 1981;54:357-365.
21. Kanamaru K, Waga S, Kojima T, et al: Endothelium-dependent relaxation of canine basilar arteries. 2. Inhibition by hemoglobin and cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage. Stroke 1987;18:938-943.
22. Gaetani P, Marzatico F, Rindi G, et al: Cerebral vasospasm: clinical and experimental aspects. Minerva Med 1986;77:1079-1086.
23. Chyatte D: Prevention of chronic cerebral vasospasm in dogs with ibuprofen and high-dose methylprednisolone. Stroke 1989;20:1021-1026.
24. D'Avella D, Germano A, Santoro G, et al: Effect of experimental subarachnoid hemorrhage on CSF eicosanoids in the rat. J Neurotrauma 1990;7:121-129.
25. Parfenova H, Shibata M, Leffler CW: Subarachnoid blood causes pial arteriolar constriction in newborn pigs. Stroke 1993;24:1729-1734.
26. Pickard JD, Walker V, Brandt L, et al: Effect of intraventricular haemorrhage and rebleeding following subarachnoid haemorrhage on CSF eicosanoids. Acta Neurochir (Wien) 1994;129:152-157.
27. Toda N, Kawakami M, Yoshida K: Constrictor action of oxyhemoglobin in monkey and dog basilar arteries in vivo and in vitro. Am J Physiol 1991;260:H420-H425.
28. Walker V, Pickard JD, Smythe P, et al: Effects of subarachnoid haemorrhage on intracranial prostaglandins. J Neurol Neurosurg Psychiatry 1983;46:119-125.
29. Kondo K, Seo R, Omawari N, et al: Effects of ONO-3708, an antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on blood vessels. Eur J Pharmacol 1989;168:193-200.
30. Takeuchi H, Tanabe M, Okamoto H, et al: Effects of thromboxane synthetase inhibitor (RS-5186) on experimentally-induced cerebral vasospasm. Neurol Res 1999;21:513-516.
31. Tokiyoshi K, Ohnishi T, Nii Y: Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage. Surg Neurol 1991;36:112-118.
32. Toshima Y, Satoh S, Ikegaki I, et al: Thromboxane A2 synthetase inhibitor failed to ameliorate the arterial narrowing during the chronic phase of cerebral vasospasm. Life Sci 1997;61:1371-1377.
33. Yokota M, Tani E, Fukumori T, et al: Effects of subarachnoid hemorrhage and a thromboxane A2 synthetase inhibitor on intracranial prostaglandins. Surg Neurol 1991;35:345-349.
34. Vollrath BA, Chan P, Findlay M, et al: Lazaroids and deferoxamine attenuate the intracellular effects of oxyhemoglobin in vascular smooth muscle. Cardiovasc Res 1995;30:619-626.
35. Kawanabe Y, Masaki T, Hashimoto N: Involvement of phospholipase C in endothelin 1-induced stimulation of Ca++ channels and basilar artery contraction in rabbits. J Neurosurg 2006;105:288-293.
36. Ureña J, Del Valle-Rodríguez A, López-Barneo J: Metabotropic Ca2+ channel-induced calcium release in vascular smooth muscle. Cell Calcium 2007;42:513-520.
37. Del Valle-Rodríguez A, Calderón E, Ruiz M, Ordoñez A, López-Barneo J, Ureña J: Metabotropic Ca(2+) channel-induced Ca(2+) release and ATP-dependent facilitation of arterial myocyte contraction. Proc Natl Acad Sci USA 2006;103:4316-4321.
38. Jewell RP, Saundry CM, Bonev AD, Tranmer BI, Wellman GC: Inhibition of Ca++ sparks by oxyhemoglobin in rabbit cerebral arteries. J Neurosurg 2004;100:295-302.
39. Dorhout Mees S, Rinkel G, Feigin V, Algra A, van den Bergh W, Vermeulen M, van Gijn J: Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007;3:CD000277.